TOP2A/MCM2, p16INK4a, and cyclin E1 expression in liquid-based cytology: a biomarkers panel for progression risk of cervical premalignant lesionsÓscar Del Moral-Hernández, Berenice Illades‐Aguiar|BMC Cancer|2021Cited by 16